CS
China SXT Pharmaceuticals Inc
🇺🇸XNAS.SXTCUnited StatesHealthcare
$2.19USDdown -0.23 (-9.5%)ClosedEnd of day1:49 AM
Price$2.19-0.23 (-9.5%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- VGG2161P1320
- CUSIP
- G2161P108
Company
- Employees
- 56
- Headquarters
- Taizhou, United States
- Website
- https://www.sxtchina.com
- CEO
- Mr. Feng Zhou
Market
- Shares outstanding
- 1.3M
- Market cap
- $2.89M
Key dates
- Next earnings
- Oct 7, 2026
Highlights
- Market cap
- $3.2M
- EPS LTM
- -$8.18
- P/E LTM
- -0.26
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $2.08M
- Net income
- -$4.79M
- Gross margin
- 48.5%
- Free cash flow
- -$5.79M
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.